1. Search Result
Search Result
Results for "

rhuMAb

" in MedChemExpress (MCE) Product Catalog:

2

Inhibitors & Agonists

5

Inhibitory Antibodies

Cat. No. Product Name Target Research Area
  • HY-P9984
    Etrolizumab
    2 Publications Verification

    rhuMAb Beta7; RG7413; PRO145223

    Integrin Cancer
    Etrolizumab (rhuMAb Beta7) is a gut-selective, anti-β7 integrin monoclonal antibody. Etrolizumab is specific targeting of the β7 subunit of α4β7 and αEβ7 integrins with Ki values of 18 nM and 1800 pM for Human α4β7 and Human αEβ7-293, respectively. Etrolizumab can be used in research of inflammatory bowel disease (IBD) .
  • HY-P9950
    Omalizumab
    1 Publications Verification

    Olizumab; rhuMAb-E25

    Inhibitory Antibodies Inflammation/Immunology Cancer
    Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE) with a KD of 0.393 nM. Omalizumab binds to the human FcγRIIb receptors with a KD of 6.37 uM. Omalizumab has the potential for persistent allergic asthma research .
  • HY-P99286

    PRO 95780; rhuMAb-DR 5; Anti-Human DR5 Recombinant Antibody

    Apoptosis Cancer
    Drozitumab (PRO 95780) is a human agonistic monoclonal antibody which binds the death receptor DR5. Drozitumab has potent antitumor activity against rhabdomyosarcoma .
  • HY-P99267

    rhuMAb IFNalpha; Anti-Human IFN alpha Recombinant Antibody

    Inhibitory Antibodies Inflammation/Immunology
    Rontalizumab is a humanized IgG1 monoclonal antibody targets IFN-α. Rontalizumab can be used for the research of systemic lupus erythematosus[1].
  • HY-P99946

    rhuMAb

    Inhibitory Antibodies Inflammation/Immunology

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: